ARCHIVES

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

Public Forum On NRSA Tuition Policies

April 14, 1995

FDA’s Jane Henney

February 11, 1994

More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010.

July 29, 2005

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

July 26, 1985

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014